what are the two glp 1 drugs MCT2D GLP-1 receptor agonists are increasingly

We host a range of products to help you make the most of your journey

Quality assessment and critical appraisal for the systematic review of the included studies The methodological quality of the included studies was evaluated independently by two reviewers using the Study Quality Assessment Tools developed by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), tailored to the design of each included study

The study compared patients who were taking GLP-1 medications with an equal number of matched patients who were not using the drugs

Research is ongoing to improve bioavailability and chemical stability for MASLD therapy